Gene Symbol | CBLC |
---|---|
Entrez Gene | 23624 |
Alt Symbol | CBL-3, CBL-SL, RNF57 |
Species | Human |
Gene Type | protein-coding |
Description | Cbl proto-oncogene C, E3 ubiquitin protein ligase |
Other Description | Cas-Br-M (murine) ecotropic retroviral transforming sequence c|Cas-Br-M (murine) ectropic retroviral transforming sequence c|Cbl proto-oncogene, E3 ubiquitin protein ligase C|E3 ubiquitin-protein ligase CBL-C|RING finger protein 57|SH3-binding protein CBL-3|SH3-binding protein CBL-C|signal transduction protein CBL-C |
Swissprots | Q8N1E5 Q9ULV8 Q9Y5Z3 Q9Y5Z2 |
Accessions | EAW57292 EAW57293 Q9ULV8 AB028645 BAA86298 AF117646 AAD34341 AF117647 AAD34342 BC028915 AAH28915 BF835530 DQ891243 ABM82169 DQ894493 ABM85419 XM_005258696 XP_005258753 XM_011526688 XP_011524990 XM_011526689 XP_011524991 XM_011526690 XP_011524992 XR_243917 XR_935783 NM_001130852 NP_001124324 NM_012116 NP_036248 |
Function | Acts as an E3 ubiquitin-protein ligase, which accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes, and then transfers it to substrates promoting their degradation by the proteasome. Functionally coupled with the E2 ubiquitin-protein ligases UB2D1, UB2D2 and UB2D3. Regulator of EGFR mediated signal transduction; upon EGF activation, ubiquitinates EGFR. Isoform 1, but not isoform 2, inhibits EGF stimulated MAPK1 activation. Promotes ubiquitination of SRC phosphorylated at 'Tyr-419'. In collaboration with CD2AP may act as regulatory checkpoint for Ret signaling by modulating the rate of RET degradation after ligand activation; CD2AP converts it from an inhibitor to a promoter of RET degradation; the function limits the potency of GDNF on neuronal survival. {ECO:0000269|PubMed:10362357, ECO:0000269|PubMed:14661060, ECO:0000269|PubMed:18753381, ECO:0000269|PubMed:20525694, ECO:0000269|PubMed:23145173}. |
Tissue Specificity | Ubiquitous. {ECO:0000269|PubMed:10362357}. |
Top Pathways | Proteoglycans in cancer, Ubiquitin mediated proteolysis, Bacterial invasion of epithelial cells, Endocytosis, ErbB signaling pathway |
Cbl-3 (F-2) - sc-390648 from Santa Cruz Biotechnology
|
||||||||||
Cbl-3 (G-6) - sc-390649 from Santa Cruz Biotechnology
|
||||||||||
Cbl-3 (C-17) - sc-8372 from Santa Cruz Biotechnology
|
||||||||||
Cbl-3 (N-19) - sc-8371 from Santa Cruz Biotechnology
|
||||||||||
Cbl-3 (H-128) - sc-292815 from Santa Cruz Biotechnology
|
||||||||||
Anti-Cbl-c antibody - ab34750 from Abcam
|
||||||||||
Anti-Cbl-c antibody [3D9] - ab139329 from Abcam
|
||||||||||
Anti-Cbl-c antibody - C-terminal - ab200094 from Abcam
|
||||||||||
Anti-CBLC Antibody (clone 3D9) - LS-C174117 from LifeSpan Bioscience
|
||||||||||
Anti-CBLC Antibody (N-Terminus, PE) - LS-C275744 from LifeSpan Bioscience
|
||||||||||
Anti-CBLC Antibody - LS-C306754 from LifeSpan Bioscience
|
||||||||||
Anti-CBLC Antibody - LS-C309731 from LifeSpan Bioscience
|
||||||||||
Anti-CBLC Antibody (aa73-395) - LS-C311714 from LifeSpan Bioscience
|
||||||||||
Anti-CBLC Antibody (aa253-448) - LS-C311855 from LifeSpan Bioscience
|
||||||||||
Anti-CBLC Antibody (N-Terminus) - LS-C326979 from LifeSpan Bioscience
|
||||||||||
Anti-CBLC Antibody (N-Terminus) - LS-C326980 from LifeSpan Bioscience
|
||||||||||
Anti-CBLC Antibody (aa1-30) - LS-C98809 from LifeSpan Bioscience
|
||||||||||
Anti-CBLC Antibody (aa424-453) - LS-C98810 from LifeSpan Bioscience
|
||||||||||
Anti-CBLC Antibody (clone 3B4) - LS-C174127 from LifeSpan Bioscience
|
||||||||||
Anti-CBLC Antibody (aa244-474, clone 4E3) - LS-C337820 from LifeSpan Bioscience
|
||||||||||
Anti-CBLC Antibody (aa444-458) IHC-plus⢠- LS-B208 from LifeSpan Bioscience
|
||||||||||
Anti-CBLC Antibody (C-Terminus, AP) - LS-C275728 from LifeSpan Bioscience
|
||||||||||
Anti-CBLC Antibody (C-Terminus, APC) - LS-C275729 from LifeSpan Bioscience
|
||||||||||
Anti-CBLC Antibody (C-Terminus, Biotin) - LS-C275731 from LifeSpan Bioscience
|
||||||||||
Anti-CBLC Antibody (C-Terminus, FITC) - LS-C275734 from LifeSpan Bioscience
|